Aethlon Gross Margin from 2010 to 2024

AEMD Stock  USD 1.71  0.04  2.29%   
Check Aethlon Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aethlon main balance sheet or income statement drivers, such as Interest Expense of 158.4 M, Other Operating Expenses of 15.1 M or Total Operating Expenses of 15.1 M, as well as many exotic indicators such as Price To Sales Ratio of 14.85, Dividend Yield of 0.0063 or Operating Cycle of 106. Aethlon financial statements analysis is a perfect complement when working with Aethlon Medical Valuation or Volatility modules.
  
This module can also supplement Aethlon Medical's financial leverage analysis and stock options assessment as well as various Aethlon Medical Technical models . Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

About Aethlon Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Aethlon Medical income statement, its balance sheet, and the statement of cash flows. Aethlon Medical investors use historical funamental indicators, such as Aethlon Medical's Gross Margin, to determine how well the company is positioned to perform in the future. Although Aethlon Medical investors may use each financial statement separately, they are all related. The changes in Aethlon Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aethlon Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aethlon Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aethlon Medical. Please read more on our technical analysis and fundamental analysis pages.
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

Pair Trading with Aethlon Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aethlon Stock

  0.61MBOT Microbot Medical Earnings Call TomorrowPairCorr
  0.71DYNT Dynatronics Financial Report 9th of May 2024 PairCorr

Moving against Aethlon Stock

  0.86NYXH Nyxoah Financial Report 21st of May 2024 PairCorr
  0.63FEMY Femasys Report 4th of April 2024 PairCorr
  0.62OMIC Singular Genomics Systems Financial Report 14th of May 2024 PairCorr
  0.59CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr
  0.53NVNO EnVVeno Medical Corp Financial Report 6th of May 2024 PairCorr
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Aethlon Stock analysis

When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.01)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.47)
Return On Equity
(0.98)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.